Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 9/13/2024Organon Enters into China Licensing Deal for Fertility Asset with Bao ...
  • 9/13/2024Fosun Pharma to Acquire Full Ownership of Fosun Kite and Strengthens P...
  • 9/12/2024Allergan Aesthetics Launches BOTOX Cosmetic for MMP in China
  • 9/11/2024UKM and ChemPartner Forge Strategic Alliance to Revolutionize Medical ...
  • 9/11/2024China to Implement Comprehensive Measures to Enhance Insurance Sector ...
  • 9/10/2024AstraZeneca CEO Defends China Business amid Staff Arrests
  • 9/9/2024China Eases Foreign Investment Restrictions on Manufacturing, Healthc...
  • 9/9/2024JIXING Announces Positive Results from Phase 3 JX02002 Trial of Etripa...
  • 9/6/2024AstraZeneca Agrees Clinical Research Deal on Solid Tumors with BestBra...
  • 9/5/2024China to Waive Import Tariffs on Drugs and Medical Devices in Hainan's...
  • 9/5/2024China Detains Five AstraZeneca Employees for 'Data Privacy' Breach an...
  • 9/5/2024CSL Disposes Wuhan Plasma Collection and Fractionation Operations
  • 9/5/2024A Share-listed MedPharm Cos Report H1/2024 Performance
  • 9/5/2024Biotheus Launches Phase 1/2 Trial for PM8002 and PM1009 Combo in Metas...
  • 9/4/2024EpimAb and Vignette Enter Strategic Deal to Develop BCMA×CD3 bsAb
  • 9/3/2024Hygieia Pharma Secures Series A2 Financing, Raising Tens of CNY Millio...
  • 9/3/2024CGeneTech Completes Series C Financing, Secures Over CNY 100M
  • 9/3/2024Simcere Zaiming Collaborates with TargetRx to introduce A Third-genera...
  • 9/2/2024Navigator Medicines Announces $100M Series A Financing and In-Licensin...
  • 9/2/2024YolTech Enters Licensing Deal with Salubris for Development and Commer...
  • 8/30/2024Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor...
  • 8/28/2024Mundipharma Fails to Sell China Unit for the Second Time Amidst High V...
  • 8/27/2024Duality Biothera Seeks Hong Kong IPO to Advance BioNTech-Collaborated ...
  • 8/27/2024Hengrui Secures Chinese Approval of IL-17A mAb, Vunakizumab
  • 8/27/2024Sanofi Suspends Supply and Sale of Flu Vaccine in China
  • 8/27/2024Legend Biotech Wins Chinese Approval of CAR-T Carvykti (Cilta-cel)
  • 8/26/2024Chinese Pharma Cos Set Sights on Dominating Therapeutic Cancer Vaccine...
  • 8/26/2024BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/S...
  • 8/26/2024Akeso Biopharma Registers New Phase III Clinical Trial for AK112 in Ch...
  • 8/26/2024UCB Sells Chinese Neurology and Allergy Business for $680M
  • Page:15/21 Total number of articles:605: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group